Malignant thymoma

L. S. Wang, M. H. Huang, T. S. Lin, B. S. Huang, K. Y. Chien

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Sixty-one patients underwent operations for malignant thymomas between 1961 and 1989. Twenty-three patients had associated myasthenia gravis (MG), an incidence of 37.7%. Upon being admitted to the hospital, the patients' most common symptoms included chest pain, MG, cough, and dyspnea. Only 7 of 61 (11.5%) patients had no symptom. Tumor staging of 58 patients with invasive thymomas was performed according to Masaoka classification. The patients were classified as follows: Stage II disease, 5; Stage III, 41; Stage IVa, 8; and Stage IVb, 4. In addition, thymic carcinoma was present in three patients. The series had a resection rate of 55.7%. The incidence of operative complications was 16.3%. Only one patient died of myocardial infarction; the incidence of operative mortality was 1.6%. The patients with MG had a higher rate of resection (69.6%) and a higher incidence of complete thymectomy (14 of 23 patients; 60.9%). Mixed lymphoepithelial tumors and epithelial cell predominant tumors were the most frequent histologic patterns (45.9% and 34.4%, respectively). Fifty-two patients had postoperative radiation therapy, and 10 patients had chemotherapy. The overall cumulative survival rates in the series were 59% and 34% at 5 and 10 years, respectively. The results demonstrated that the factors affecting the prognosis may include resectability, postoperative irradiation or chemotherapy, MG, and tumor staging. The influence of histologic variation on survival rates could not be clearly defined in the series. Surgical resection, particularly complete thymectomy, followed by irradiation is the primary option of therapeutic management for malignant thymoma.

Original languageEnglish
Pages (from-to)443-450
Number of pages8
JournalCancer
Volume70
Issue number2
DOIs
Publication statusPublished - 1992
Externally publishedYes

Fingerprint

Thymoma
Myasthenia Gravis
Thymectomy
Neoplasm Staging
Incidence
Survival Rate
Drug Therapy
Chest Pain
Cough
Dyspnea
Neoplasms
Radiotherapy
Epithelial Cells
Myocardial Infarction

Keywords

  • malignant thymoma
  • myasthenia gravis
  • thymectomy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Wang, L. S., Huang, M. H., Lin, T. S., Huang, B. S., & Chien, K. Y. (1992). Malignant thymoma. Cancer, 70(2), 443-450. https://doi.org/10.1002/1097-0142(19920715)70:2<443::AID-CNCR2820700212>3.0.CO;2-T

Malignant thymoma. / Wang, L. S.; Huang, M. H.; Lin, T. S.; Huang, B. S.; Chien, K. Y.

In: Cancer, Vol. 70, No. 2, 1992, p. 443-450.

Research output: Contribution to journalArticle

Wang, LS, Huang, MH, Lin, TS, Huang, BS & Chien, KY 1992, 'Malignant thymoma', Cancer, vol. 70, no. 2, pp. 443-450. https://doi.org/10.1002/1097-0142(19920715)70:2<443::AID-CNCR2820700212>3.0.CO;2-T
Wang LS, Huang MH, Lin TS, Huang BS, Chien KY. Malignant thymoma. Cancer. 1992;70(2):443-450. https://doi.org/10.1002/1097-0142(19920715)70:2<443::AID-CNCR2820700212>3.0.CO;2-T
Wang, L. S. ; Huang, M. H. ; Lin, T. S. ; Huang, B. S. ; Chien, K. Y. / Malignant thymoma. In: Cancer. 1992 ; Vol. 70, No. 2. pp. 443-450.
@article{f25cb4931c1844d7afb5310839404556,
title = "Malignant thymoma",
abstract = "Sixty-one patients underwent operations for malignant thymomas between 1961 and 1989. Twenty-three patients had associated myasthenia gravis (MG), an incidence of 37.7{\%}. Upon being admitted to the hospital, the patients' most common symptoms included chest pain, MG, cough, and dyspnea. Only 7 of 61 (11.5{\%}) patients had no symptom. Tumor staging of 58 patients with invasive thymomas was performed according to Masaoka classification. The patients were classified as follows: Stage II disease, 5; Stage III, 41; Stage IVa, 8; and Stage IVb, 4. In addition, thymic carcinoma was present in three patients. The series had a resection rate of 55.7{\%}. The incidence of operative complications was 16.3{\%}. Only one patient died of myocardial infarction; the incidence of operative mortality was 1.6{\%}. The patients with MG had a higher rate of resection (69.6{\%}) and a higher incidence of complete thymectomy (14 of 23 patients; 60.9{\%}). Mixed lymphoepithelial tumors and epithelial cell predominant tumors were the most frequent histologic patterns (45.9{\%} and 34.4{\%}, respectively). Fifty-two patients had postoperative radiation therapy, and 10 patients had chemotherapy. The overall cumulative survival rates in the series were 59{\%} and 34{\%} at 5 and 10 years, respectively. The results demonstrated that the factors affecting the prognosis may include resectability, postoperative irradiation or chemotherapy, MG, and tumor staging. The influence of histologic variation on survival rates could not be clearly defined in the series. Surgical resection, particularly complete thymectomy, followed by irradiation is the primary option of therapeutic management for malignant thymoma.",
keywords = "malignant thymoma, myasthenia gravis, thymectomy",
author = "Wang, {L. S.} and Huang, {M. H.} and Lin, {T. S.} and Huang, {B. S.} and Chien, {K. Y.}",
year = "1992",
doi = "10.1002/1097-0142(19920715)70:2<443::AID-CNCR2820700212>3.0.CO;2-T",
language = "English",
volume = "70",
pages = "443--450",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Malignant thymoma

AU - Wang, L. S.

AU - Huang, M. H.

AU - Lin, T. S.

AU - Huang, B. S.

AU - Chien, K. Y.

PY - 1992

Y1 - 1992

N2 - Sixty-one patients underwent operations for malignant thymomas between 1961 and 1989. Twenty-three patients had associated myasthenia gravis (MG), an incidence of 37.7%. Upon being admitted to the hospital, the patients' most common symptoms included chest pain, MG, cough, and dyspnea. Only 7 of 61 (11.5%) patients had no symptom. Tumor staging of 58 patients with invasive thymomas was performed according to Masaoka classification. The patients were classified as follows: Stage II disease, 5; Stage III, 41; Stage IVa, 8; and Stage IVb, 4. In addition, thymic carcinoma was present in three patients. The series had a resection rate of 55.7%. The incidence of operative complications was 16.3%. Only one patient died of myocardial infarction; the incidence of operative mortality was 1.6%. The patients with MG had a higher rate of resection (69.6%) and a higher incidence of complete thymectomy (14 of 23 patients; 60.9%). Mixed lymphoepithelial tumors and epithelial cell predominant tumors were the most frequent histologic patterns (45.9% and 34.4%, respectively). Fifty-two patients had postoperative radiation therapy, and 10 patients had chemotherapy. The overall cumulative survival rates in the series were 59% and 34% at 5 and 10 years, respectively. The results demonstrated that the factors affecting the prognosis may include resectability, postoperative irradiation or chemotherapy, MG, and tumor staging. The influence of histologic variation on survival rates could not be clearly defined in the series. Surgical resection, particularly complete thymectomy, followed by irradiation is the primary option of therapeutic management for malignant thymoma.

AB - Sixty-one patients underwent operations for malignant thymomas between 1961 and 1989. Twenty-three patients had associated myasthenia gravis (MG), an incidence of 37.7%. Upon being admitted to the hospital, the patients' most common symptoms included chest pain, MG, cough, and dyspnea. Only 7 of 61 (11.5%) patients had no symptom. Tumor staging of 58 patients with invasive thymomas was performed according to Masaoka classification. The patients were classified as follows: Stage II disease, 5; Stage III, 41; Stage IVa, 8; and Stage IVb, 4. In addition, thymic carcinoma was present in three patients. The series had a resection rate of 55.7%. The incidence of operative complications was 16.3%. Only one patient died of myocardial infarction; the incidence of operative mortality was 1.6%. The patients with MG had a higher rate of resection (69.6%) and a higher incidence of complete thymectomy (14 of 23 patients; 60.9%). Mixed lymphoepithelial tumors and epithelial cell predominant tumors were the most frequent histologic patterns (45.9% and 34.4%, respectively). Fifty-two patients had postoperative radiation therapy, and 10 patients had chemotherapy. The overall cumulative survival rates in the series were 59% and 34% at 5 and 10 years, respectively. The results demonstrated that the factors affecting the prognosis may include resectability, postoperative irradiation or chemotherapy, MG, and tumor staging. The influence of histologic variation on survival rates could not be clearly defined in the series. Surgical resection, particularly complete thymectomy, followed by irradiation is the primary option of therapeutic management for malignant thymoma.

KW - malignant thymoma

KW - myasthenia gravis

KW - thymectomy

UR - http://www.scopus.com/inward/record.url?scp=0026634924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026634924&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19920715)70:2<443::AID-CNCR2820700212>3.0.CO;2-T

DO - 10.1002/1097-0142(19920715)70:2<443::AID-CNCR2820700212>3.0.CO;2-T

M3 - Article

C2 - 1617594

AN - SCOPUS:0026634924

VL - 70

SP - 443

EP - 450

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 2

ER -